Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (24777)	8/19/1998 9:18:00 AM
From: dwc	Respond to of 32384

To all: FYI ENGLEWOOD, N.J.--(BUSINESS WIRE)--Aug. 11, 1998--Individual investors in the New York metropolitan area are invited to participate in the first Informed Investors New York Metro BioPharma Stocks Forum on Saturday morning Sept. 12 at the Englewood Radisson Hotel. Executives from a minimum of eight companies will present their prospects at the Forum. Companies committed thus far are Genentech (NYSE:GNE), Inhale Therapeutics (NASDAQ:INHL), SunPharm (NASDAQ:SUNP) and Alteon Inc. (NASDAQ:ALTN). Also, Jim McCamant, editor of the Medical Technology Stock Letter (www.bioinvest.com), will be one keynote speaker. A second keynote speaker plus other presenting companies are pending. The cost to attend is $25 prepaid, $40 at the door. The Forum will run from 8:30 a.m.-12:30 p.m. and includes a continental breakfast. Call Informed Investors at 800/992-4683 to register. Audio tapes for the full set (five cassettes) are $48.95 which includes all company presentations plus keynote speakers. Individual tapes are $18. Access Informed Investors' website at informedinvestors.com for more information and updates. "We are excited about our first New York Forum," said Steve Chanecka, President of Sacramento,Calif.-based Informed Investors, Inc., organizer of the Forums. "Investors in the region are among the most sophisticated anywhere and I believe they will respond well to the 'analyst-style' format individual investors throughout the country have found so worthwhile. "We provide a valuable, inexpensive resource for investors who are shut out from investment banking conferences -- they are closed to individual investors -- because we level the playing field for them," Chanecka added. "Attendees and those who order tapes/transcripts get much more insight into a company's prospects than simply reading an annual report or 10-K. It's an opportunity to 'see the whites of their eyes' when watching executives present. One gets a feeling about them, their body language, the way they carry themselves. The Q&A periods are usually quite lively, too. "I encourage New York investors to sample our Forum," Chanecka said. "I think their expectations will be exceeded. Likewise, company executives are almost always surprised at the quality of our audiences, the questions they ask, the industry knowledge, etc. It's a stimulating atmosphere." Three days later, on Tuesday Sept. 15, Informed Investors will be holding its first Boston Biotechnology Stocks Forum at the Back Bay Hilton. The Forum runs from 8:30 a.m.-4 p.m. In Boston, biotech analysts Meg Malloy of Hambrecht & Quist and Eric Schmidt, Ph.D of Cowen & Co. are the keynote speakers. The cost to attend is $40 prepaid, $55 at the door. Call 800/992-4683 to register. Audio tapes (seven cassettes) are $50 plus $4.95 S/H which includes all company presentations plus keynote speakers. Individual tapes are $18. Transcripts of the Malloy's and Schmidt's comments are $25 or $15 when tapes are purchased. In addition to Malloy and Schmidt, executives from 12 biotechnology companies will give 20-25 minute presentations, followed by Q&A, which replicate the format common at industry investment banking conferences. The presenting companies are: Biogen (Nasdaq:BGEN); Biosource International(Nasdaq:BIOI); Boston Life Sciences (Nasdaq:BLSI); Creative BioMolecules (Nasdaq:CBMI);Genzyme Tissue Repair (Nasdaq:GENZL); Genzyme Transgenics (Nasdaq:GZTC); Ilex Oncology (Nasdaq:ILXO); Integra LifeSciences (Nasdaq:IART); Ligand Pharmaceuticals (Nasdaq:LGND);Repligen (Nasdaq:RGEN); T Cell Sciences (Nasdaq:TCEL) and XOMA Corp. (Nasdaq:XOMA). Since 1993, Informed Investors has featured scores of quality companies and industry experts at its Forums. Informed Investors represents individual investors who collectively hold an estimated $2 billion in investable assets.